Experience with Implanon in a North East London family planning clinic

Experience with Implanon in a North East London family planning clinic

S. Gupta, K. Rai

Young People and Women’s Service, Hurst Road Health Centre, Walthamstow,

London, UK

Introduction: A retrospective survey of patients’ notes was

conducted to evaluate the long-term contraceptive implant (Implanon) in Waltham

Forest, London.

Objective: To determine continuation rates of this new long-term hormonal


Results: Of the 142 implants fitted over the 3 year period (February

2000 to January 2003), 132 notes could be retrieved for retrospective analysis.

Of the 132 women, 93% were self-referrals, 5% were from GPs and 2% were from

Secondary care. Preinsertion counselling was undertaken in 97%. The median age

of fitting was 25 years. The most common indications for choosing implants were

choice of a long acting method, suboptimal, compliance with pills or injectables,

bad experience with other methods, associated medical conditions and prior usage

of Norplant. 27 women (20%) required medical intervention for bleeding problems,

in 8 women (30%) bleeding resolved with treatment, 4 women (15%) are continuing

with medical treatment, in 12 women (44%) Implanon was removed due to failure of

bleeding problems to resolve with medical treatment. No pregnancies have been

reported so far based on a follow-up of 85% of women. 15% women were lost to

both virtual and telephonic follow up. 22 implants have been removed by the end

of the study period, with 60% (n=12/22) removals attributed to bleeding problems.

The assumed lifetimes of Implanon using Kaplan Meier method are 0.90 at

12months, 0.80 at 24 months and 0.75 at 35 months. The confirmed life times are

0.84 at 12 months, 0.63 at 24 months and 0.53 at 35 months.

Conclusion: In our experience, Implanon is proving to be a highly

effective, long acting hormonal method of contraception with reasonable

continuation rates at 2 and 3 years. Effective pre and post insertion

counselling is important in patients acceptance of side effects and has an

enormous impact on continuation rates.

Scroll to Top